Table I.
Donor-Cell line | peptide | γδ w/o peptide | γδ + peptide | DCs w/o peptide | DCs + peptide |
---|---|---|---|---|---|
A-1 | RAK | 7.0% | 60.0% | n.d. | 82.0% |
A-2 | RAK | n.d. | 67.7% | n.d. | 83.0% |
A-3 | RAK | 6.5% | 89.7% | 2.0% | 89.2% |
B-1 | RAK | 6.0% | 80.0% | 2.0% | 96.0% |
B-2 | RAK | 3.1% | 63.0% | 3.2% | 93.0% |
B-3 | RAK | 2.8% | 55.5% | n.d. | n.d. |
C-1 | RAK | 2.4% | 53.0% | n.d. | n.d. |
D-1 | RAK | 2.0% | 41.9% | n.d. | 10.6% |
E-1 | RAK | 1.3% | 8.3% | 3.0% | 13.4% |
E-2 | RAK | 0.9% | 8.5% | n.d. | n.d. |
E-3 | RAK | 0.9% | 35.0% | 0.9% | 49.0% |
mean | 3.3% | 51.1% | 2.2% | 64.5% |
C-1 | FLY | 0.7% | 10.0% | 1.3% | 22.8% |
C-2 | FLY | 0.2% | 15.2% | n.d. | n.d. |
C-3 | FLY | 1.4% | 13.3% | 1.3% | 21.6% |
C-4 | FLY | 1.0% | 30.2% | n.d. | 29.0% |
C-5 | FLY | 1.6% | 14.6% | n.d. | n.d. |
F-1 | FLY | 1.0% | 4.3% | n.d. | n.d. |
F-2 | FLY | 1.1% | 4.9% | n.d. | n.d. |
F-3 | FLY | 0.4% | 8.1% | n.d. | 9.0% |
G-1 | FLY | 0.8% | 33.2% | n.d. | n.d. |
H-1 | FLY | 1.0% | 5.8% | n.d. | n.d. |
H-2 | FLY | 0.7% | 2.1% | n.d. | n.d. |
H-3 | FLY | 0.7% | 1.6% | 0.5% | 1.2% |
mean | 0.9% | 12.6% | 1.0% | 16.7% |